Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$233.35 +0.34 (+0.14%)
As of: Oct 2, 2026 · 9:40 AM EDT

Jazz Pharmaceuticals (JAZZ) Non-Current Deffered Revenue (2010 - 2022)

Updated

Jazz Pharmaceuticals (JAZZ) posted Non-Current Deffered Revenue of $116,000 for Q3 2022, down 88.2% from $986,000 a year earlier and down 49.8% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Non-Current Deffered Revenue (2010 - 2022) Analysis & Trends

At the end of FY2021, Jazz Pharmaceuticals' Non-Current Deffered Revenue came in at $463,000, down 80.0% from FY2020.

  • Annual Non-Current Deffered Revenue has declined for four consecutive years, with a five-year compound annual growth rate of -29.2% (FY2016 to FY2021).
  • In prior years, Jazz Pharmaceuticals' Non-Current Deffered Revenue was $2.32 million in FY2020 (-52.4%), $4.86 million in FY2019 (-49.3%), $9.58 million in FY2018 (-40.5%) and $16.12 million in FY2017 (+519.6%).
  • The Q3 2022 figure stands as the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2010.
  • On a year-over-year basis, Non-Current Deffered Revenue has declined in each of the last 19 quarters, with an average decline of 70.9% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q4 2017, with growth of 519.6%; the weakest was Q3 2022, with a decline of 88.2%.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $231,000 (Q2 2022), $347,000 (Q1 2022) and $463,000 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Jazz Pharmaceuticals 15.03 Bn 8.85 Bn 1.09 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 116,000.00
Jun 30, 2022 231,000.00
Mar 31, 2022 347,000.00
Dec 31, 2021 463,000.00
Sep 30, 2021 986,000.00
Jun 30, 2021 1.51 Mn
Mar 31, 2021 1.85 Mn
Dec 31, 2020 2.32 Mn
Sep 30, 2020 2.95 Mn
Jun 30, 2020 3.59 Mn
Mar 31, 2020 4.23 Mn
Dec 31, 2019 4.86 Mn
Sep 30, 2019 6.04 Mn
Jun 30, 2019 7.22 Mn
Mar 31, 2019 8.40 Mn
Dec 31, 2018 9.58 Mn
Sep 30, 2018 10.93 Mn
Jun 30, 2018 12.29 Mn
Mar 31, 2018 13.64 Mn
Dec 31, 2017 16.12 Mn
API Access

Jazz Pharmaceuticals Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=JAZZ&period=max&api_key=YOUR_API_KEY